Venous Thromboembolism guide history

Document Title

Clinical Guideline for Primary Prophylaxis for Venous Thromboembolism(VTE) in the palliative care setting

Document Date

March 2024

Document Purpose and Intended Audience

For use by palliative medicine specialists

Author

Dr Anna Lock
Dr Nadia Khan
Dr Laura Holtham

Consultation Process

Version 3.2 reviewed March 2024. Nil amendments agreed in consultation with SPAGG membership group according to professional opinion and feedback

Monitoring

This will be audited and reviewed every 3 years

Review Date

(must be within three years)

March 2027

Approval Signatures:

SPAGG chair

Dr Jon Tomas

SPAGG secretary

Dr A. Martin

Date Approved by SPAGG: March 2024

Date submitted to Area Prescribing Committee: N/A

Version History

Version 1.0

Date

April 2008

Summary of change/ process

  • Endorsed and approved by Governance Committee

Version 1.1 - 1.6

Date

June 2011 - August 2011

Summary of change/ process

  • Updated by Anna Lock
  • Re-circulated to and approved by SPAGG on behalf of the
  • Supportive and Palliative Care NSSG
  • Reformatted by Lara Barnish
  • With changes by Anna Lock
  • Circulated to and presented at SPAGG
  • Presented at the Clinical Governance Sub Group
  • With minor amendments from the Sub Group, for the attention
    of Anna Lock

Version 2.0

Date

August 2011

Summary of change/ process

With comments from Anna Lock

Version 3.0

Date

November 2013 - December 2014

Summary of change/ process

  • Updated by Nadia Khan and Anna Lock, circulated to SPAGG
  • Audit of regional practice against v2.0, with outcomes informing v3.0
  • Endorsed and approved by the SPAGG committee

Version 3.1 - 3.2

Date

March 2017

Summary of change/ process

  • Reviewed by Dr Louisa Nelms, endorsed and approved by SPAGG
  • With changes from Dr Laura Holtham (March 2020)

Version 3.3

Date

March 2024

Summary of change/ process

Reviewed by Dr Nial McCarron and Dr Ben Lambert, endorsed and approved by SPAGG

Disclaimer

These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.

Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.

Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.